Identification of hub genes and discovery of promising compounds in gastric cancer based on bioinformatics analysis

Autor: Fang Wen, Peng Shu, Yingfeng Bai, Wenjie Huang, Xiaona Lu, Jiani Huang
Rok vydání: 2020
Předmět:
0301 basic medicine
Hub genes
Levallorphan
Microarray
Clinical Biochemistry
Amiodarone
Datasets as Topic
Cell Cycle Proteins
Computational biology
Resveratrol
Protein Serine-Threonine Kinases
PLK1
Collagen Type I
Small Molecule Libraries
03 medical and health sciences
chemistry.chemical_compound
Piroxicam
0302 clinical medicine
Stomach Neoplasms
Proto-Oncogene Proteins
Drug Discovery
Databases
Genetic

medicine
Humans
Gene
Vorinostat
Mechanism (biology)
business.industry
Gene Expression Profiling
Biochemistry (medical)
Ursodeoxycholic Acid
Cancer
medicine.disease
Neoplasm Proteins
Gene Expression Regulation
Neoplastic

030104 developmental biology
Ki-67 Antigen
chemistry
030220 oncology & carcinogenesis
Clomipramine
Identification (biology)
Osteopontin
business
Microtubule-Associated Proteins
Procaine
Genes
Neoplasm
Zdroj: Biomarkers in medicine. 14(12)
ISSN: 1752-0371
Popis: Aim: To explore the mechanism of gastric carcinogenesis by mining potential hub genes and to search for promising small-molecular compounds for gastric cancer (GC). Materials & methods: The microarray datasets were downloaded from Gene Expression Omnibus database and the genes and compounds were analyzed by bioinformatics-related tools and software. Results: Six hub genes ( MKI67, PLK1, COL1A1, TPX2, COL1A2 and SPP1) related to the prognosis of GC were confirmed to be upregulated in GC and their high expression was correlated with poor overall survival rate in GC patients. In addition, eight candidate compounds with potential anti-GC activity were identified, among which resveratrol was closely correlated with six hub genes. Conclusion: Six hub genes identified in the present study may contribute to a more comprehensive understanding of the mechanism of gastric carcinogenesis and the predicted potential of resveratrol may provide valuable clues for the future development of targeted anti-GC inhibitors.
Databáze: OpenAIRE